A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...
Approximately 15 to 20 million Americans who have acquired COVID-19 experience persistent symptoms lasting over 3 months (long-COVID). Respiratory symptoms of long-COVID include breathlessness, ...
"mRNA cancer vaccines sensitize tumors to immune checkpoint inhibitors (ICIs) in part by stimulating a surge in inflammatory ...
What if scientists could build a realistic model of the human lung, not full-sized, but grown in the lab from living cells?
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study Supported in part by grants (NIH P51 OD011132, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The study covered in this summary was published on BioRxiv.org as a preprint and has not yet been ...
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...
It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...
Nearly 80% of adults with a previous SARS-CoV-2 infection demonstrated a loss of smell up to 2 years later, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback